BNTC — Benitec Biopharma Balance Sheet
0.000.00%
Last trade - 00:00
- $18.12m
- -$2.25m
- $0.08m
- 21
- 12
- 100
- 40
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | 10-K | 10-K | 10-K | 10-K |
Standards: | IFRS | USG | USG | USG | USG |
Status: | fx Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 15.9 | 9.8 | 19.8 | 4.06 | 2.48 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.54 | 0.059 | 0.025 | 0.003 | 0.055 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 18.8 | 10.8 | 20.6 | 4.82 | 3.73 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.47 | 0.769 | 0.577 | 0.993 | 0.613 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 19.3 | 11.6 | 21.4 | 5.97 | 4.46 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.64 | 1.14 | 1.37 | 2.53 | 3.98 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.64 | 1.35 | 1.37 | 3.09 | 4.26 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 16.6 | 10.2 | 20 | 2.88 | 0.202 |
Total Liabilities & Shareholders' Equity | 19.3 | 11.6 | 21.4 | 5.97 | 4.46 |
Total Common Shares Outstanding |